Sign In

News Story

ACS/Pfizer aim to reduce prostate cancer disparities

Grants totaling $1.5M target gaps in care and treatment for Black men.

The American Cancer Society and Pfizer Global Medical Grants have awarded $1.5 million in one-time grants to address prostate cancer disparities impacting Black men.

The grants, funded by Pfizer Global Medical Grants and overseen by ACS, were awarded through a competitive selection process to:

  • Brigham and Women's Hospital in Massachusetts
  • Central Florida Pharmacy Council in Florida
  • Dana-Farber Cancer Institute and Emory University in Massachusetts and Georgia
  • Henry Ford Health System in Michigan
  • Mary's Center in Washington D.C.
  • Pennsylvania State University College of Medicine in Pennsylvania

Cancer is a disease that affects everyone, but it doesn’t affect everyone equally. Blacks experience more illness, worse outcomes, and premature death compared to whites in the U.S. Further, Black people have the highest death rate and shortest survival of any racial/ethnic group in the U.S. for most cancers. Black men also have the highest overall cancer incidence.

“Inclusion and equity are critical to our mission and reducing cancer disparities by race and ethnicity is an overarching goal of the American Cancer Society,” said Laura Makaroff, DO, our senior vice president, Prevention and Early Detection. “We need to make sure everyone has the ability to benefit from the advances in research, prevention, diagnosis, and treatment of cancer. These grants are an important step in advancing health equity.”

Many factors significantly impact a person's ability to prevent, find, treat, and survive cancer, including income, education, their race, ethnicity, sexual orientation, gender identity, their disability status, or where they live, work, and play.

"Despite breakthrough progress in treating prostate cancer overall, Black men living with the disease today face significant barriers to receiving optimal care,” said, Dany Habr, MD, chief medical officer, Pfizer Oncology. “We are proud to partner with the American Cancer Society and the cancer community on this initiative, and we are committed to continuing to advance health equity and reduce healthcare disparities. We look forward to seeing the impact the awarded projects can deliver in working toward this goal.” 


back to top